Biological and Biomedical Applications of Graphene-Based Materials

Dear Colleagues,

Graphene, a single layer of carbon atoms in a closely packed honeycomb two-dimensional structure, is a new kind of carbon nanostructure material that was produced for the first time in 2004. Graphene has been exploited in many applications, and the use of graphene in the biomedical field is rapidly growing. Recent years have seen an explosion of graphene-based material biomedical research, owing to the captivating physical and chemical properties of this family of nanomaterials, and thousands of scientific papers have been published since 2010, the year of the Geim and Novoselov Graphene Nobel Prize.

The versatile chemistry of graphene-based nanomaterials, including the capability to conjugate with water-soluble and water-insoluble active compounds, DNA, proteins, cells, targeting agents or polymers makes them a desirable nanoplatform for advanced biotechnological applications. Graphene derivates can be designed for drug and gene delivery applications or to realize antibacterial biocompatible scaffolds for the growth and proliferation of human stem cells. The graphene capability to confine light opens the possibility to develop ultrasensitive biosensors and can be applied for therapeutic functions together with imaging capabilities. Since graphene and graphene derivatives are a versatile platform across various biomedical disciplines, in this Special Issue, we aim to illustrate areas of promise and identify future challenges.

Prof. Dr. Massimiliano Papi
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Bioengineering is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• graphene
• graphene oxide
• drug delivery
• gene delivery
• antimicrobial
• tissue engineering
• biosensor
• imaging
• theranostics
• photothermal therapy